214 related articles for article (PubMed ID: 23683551)
1. Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential.
Frede J; Fraser SP; Oskay-Özcelik G; Hong Y; Ioana Braicu E; Sehouli J; Gabra H; Djamgoz MB
Eur J Cancer; 2013 Jul; 49(10):2331-44. PubMed ID: 23683551
[TBL] [Abstract][Full Text] [Related]
2. Ion channels or aquaporins as novel molecular targets in gastric cancer.
Xia J; Wang H; Li S; Wu Q; Sun L; Huang H; Zeng M
Mol Cancer; 2017 Mar; 16(1):54. PubMed ID: 28264681
[TBL] [Abstract][Full Text] [Related]
3. Ion channels and transporters in metastasis.
Stock C; Schwab A
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2638-46. PubMed ID: 25445667
[TBL] [Abstract][Full Text] [Related]
4. Voltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell.
Zhanping W; Xiaoyu P; Na C; Shenglan W; Bo W
Gynecol Oncol; 2007 Feb; 104(2):455-60. PubMed ID: 17014896
[TBL] [Abstract][Full Text] [Related]
5. Systems biology of ion channels and transporters in tumor angiogenesis: An omics view.
Munaron L
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2647-56. PubMed ID: 25450338
[TBL] [Abstract][Full Text] [Related]
6. Water transport between CNS compartments: functional and molecular interactions between aquaporins and ion channels.
Benfenati V; Ferroni S
Neuroscience; 2010 Jul; 168(4):926-40. PubMed ID: 20026249
[TBL] [Abstract][Full Text] [Related]
7. TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis.
Zeng B; Yuan C; Yang X; Atkin SL; Xu SZ
Curr Cancer Drug Targets; 2013 Jan; 13(1):103-16. PubMed ID: 22920441
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
Shridhar V; Bible KC; Staub J; Avula R; Lee YK; Kalli K; Huang H; Hartmann LC; Kaufmann SH; Smith DI
Cancer Res; 2001 May; 61(10):4258-65. PubMed ID: 11358853
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance.
Richardson A; Kaye SB
Drug Resist Updat; 2005 Oct; 8(5):311-21. PubMed ID: 16233989
[TBL] [Abstract][Full Text] [Related]
10. Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines.
Roger S; Rollin J; Barascu A; Besson P; Raynal PI; Iochmann S; Lei M; Bougnoux P; Gruel Y; Le Guennec JY
Int J Biochem Cell Biol; 2007; 39(4):774-86. PubMed ID: 17307016
[TBL] [Abstract][Full Text] [Related]
11. Voltage-sensitive ion channels and cancer.
Fiske JL; Fomin VP; Brown ML; Duncan RL; Sikes RA
Cancer Metastasis Rev; 2006 Sep; 25(3):493-500. PubMed ID: 17111226
[TBL] [Abstract][Full Text] [Related]
12. Ion channels in death and differentiation of prostate cancer cells.
Prevarskaya N; Skryma R; Bidaux G; Flourakis M; Shuba Y
Cell Death Differ; 2007 Jul; 14(7):1295-304. PubMed ID: 17479110
[TBL] [Abstract][Full Text] [Related]
13. Key roles of aquaporins in tumor biology.
Papadopoulos MC; Saadoun S
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2576-83. PubMed ID: 25204262
[TBL] [Abstract][Full Text] [Related]
14. Role of ion channels in gastrointestinal cancer.
Anderson KJ; Cormier RT; Scott PM
World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
[TBL] [Abstract][Full Text] [Related]
15. The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells.
Han X; Xi L; Wang H; Huang X; Ma X; Han Z; Wu P; Ma X; Lu Y; Wang G; Zhou J; Ma D
Biochem Biophys Res Commun; 2008 Oct; 375(2):205-9. PubMed ID: 18706395
[TBL] [Abstract][Full Text] [Related]
16. [Aggrephores and aquaporins].
Verbavatz JM
C R Seances Soc Biol Fil; 1995; 189(2):191-7. PubMed ID: 8590218
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells.
Isbilen B; Fraser SP; Djamgoz MB
Int J Biochem Cell Biol; 2006; 38(12):2173-82. PubMed ID: 16931105
[TBL] [Abstract][Full Text] [Related]
18. Coordinately up-regulated genes in ovarian cancer.
Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
Zhang T; Guan M; Jin HY; Lu Y
Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
